Business description not available.
| Metric | TTM | FY2021 | FY2020 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Net Income | -20M | -20M | -12M |
| EPS | $0.00 | $0.00 | $0.00 |
| Free Cash Flow | -21M | -21M | -15M |
| ROIC | -508.6% | -159.4% | -149.6% |
| Gross Margin | - | - | - |
| Debt/Equity | 0.00 | 0.10 | 0.17 |
| Dividends/Share | $0.00 | $0.00 | $0.00 |
| Operating Income | -21M | -21M | -15M |
| Operating Margin | 0.0% | - | - |
| ROE | -28.7% | -28.7% | -41.9% |
| Shares Outstanding | 0M | 0M | 0M |
| Metric | 2020 | 2021 | TTM |
|---|---|---|---|
| Income Statement | |||
| Revenue | 0 | 0 | 0 |
| Gross Margin | N/A | N/A | N/A |
| R&D | -13M | -16M | -16M |
| SG&A | N/A | N/A | N/A |
| EBIT | -15M | -21M | -21M |
| Op. Margin | N/A | N/A | 0.0% |
| Net Income | -12M | -20M | -20M |
| Net Margin | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 |
| Returns on Capital | |||
| ROIC | -149.6% | -159.4% | N/M |
| ROE | -41.9% | -28.7% | -28.7% |
| ROA | -29.6% | -24.1% | -24.1% |
| Cash Flow | |||
| Op. Cash Flow | -11M | -20M | -20M |
| Free Cash Flow | -15M | -21M | -21M |
| Owner Earnings | -13M | -22M | -22M |
| CapEx | 4.4M | 1.6M | 1.6M |
| Maint. CapEx | 1.2M | 1.7M | 1.7M |
| Growth CapEx | 3.2M | 0 | 0 |
| D&A | 1.2M | 1.7M | 1.7M |
| CapEx/OCF | N/A | N/A | 0.0% |
| Capital Allocation | |||
| Dividends Paid | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | 632K | 603K | 603K |
| Debt Repayment | 1.2M | 1.3M | 1.3M |
| Balance Sheet | |||
| Net Debt | -21M | -59M | -66M |
| Cash & Equiv. | 27M | 66M | 66M |
| Long-Term Debt | N/A | N/A | N/A |
| Debt/Equity | 0.17 | 0.10 | 0.00 |
| Interest Coverage | -77.6 | -52.7 | -52.7 |
| Equity | 29M | 70M | 70M |
| Total Assets | 42M | 83M | 83M |
| Total Liabilities | 12M | 13M | 13M |
| Intangibles | 910K | 0 | 0 |
| Retained Earnings | -39M | -66M | -66M |
| Working Capital | 22M | 63M | 63M |
| Current Assets | 29M | 70M | 70M |
| Current Liabilities | 7.1M | 6.1M | 6.1M |
| Per Share Data | |||
| EPS | 0.00 | 0.00 | 0.00 |
| Owner EPS | N/A | N/A | N/A |
| Book Value | 0.00 | 0.00 | 0.00 |
| Cash Flow/Share | 0.00 | 0.00 | 0.00 |
| Dividends/Share | 0.00 | 0.00 | 0.00 |
| Shares Out. | 0.0M | 0.0M | 0.0M |
| Valuation | |||
| P/E Ratio | N/A | N/A | N/A |
| P/FCF | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A |
| FCF Yield | N/A | N/A | N/A |
| Market Cap | 0 | 0 | 0 |
| Avg. Price | 0.00 | 8.34 | 2.18 |
| Year-End Price | 0.00 | 8.22 | 2.18 |
BIOTALYS NV passes 0 of 9 quality checks, indicating weak fundamentals.
BIOTALYS NV (BTLS-BR) has a 5-year average return on invested capital (ROIC) of -154.5%. This is below average and may indicate limited pricing power.
BIOTALYS NV (BTLS-BR) does not currently pay a regular dividend.
BIOTALYS NV (BTLS-BR) generated $-21 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
BIOTALYS NV (BTLS-BR) has a debt-to-equity ratio of 0.10. This indicates a conservatively financed balance sheet.
BIOTALYS NV (BTLS-BR) has a return on equity (ROE) of -28.7%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 2 years of financial data for BIOTALYS NV (BTLS-BR), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.